Richard Barry
CIK 1562371 · President & CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$65.68M
Companies
5
Total Filings
38
Lifetime Open-Market Net
-$7.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRPT | Director | 2,993,542 | $17.18 | $51.43M | -$12.11M | 23 | 2026-06-05 |
| CASSAVA SCIENCES INC (SAVA) Delisted | President & CEO | 938,060 | $2.34 | $2.20M | $4.63M | 11 | 2025-11-24 |
| CASSAVA SCIENCES INC (SAVAW) Delisted | Director | 469,562 | $0.03 | $14.1K | $0 | 1 | 2024-04-25 |
| MDXG | Director | 3,338,135 | $4.27 | $14.25M | $0 | 1 | 2020-08-06 |
| MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | 10%+ Owner | 30,475 | — | — | -$300.5K | 2 | 2012-12-19 |
Recent Filings · Page 2 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-13 | CASSAVA SCIENCES INC (SAVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-25 | CASSAVA SCIENCES INC (SAVAW) Delisted | Mixed | +176,085 | $3.87M | EDGAR |
| 2024-03-05 | SRPT | Grant (A) | +1,846 | $0 | EDGAR |
| 2023-11-06 | SRPT | Buy (P) | +50,000 | $3.94M | EDGAR |
| 2023-08-23 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +18,477 | $307.9K | EDGAR |
| 2023-05-08 | CASSAVA SCIENCES INC (SAVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-08 | SRPT | Grant (A) | +1,523 | $0 | EDGAR |
| 2023-03-08 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +88,841 | $2.29M | EDGAR |
| 2022-08-25 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +36,159 | $860.2K | EDGAR |
| 2022-03-08 | SRPT | Grant (A) | +2,953 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.